{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:31:09Z","timestamp":1791289869553,"version":"4.3.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03692-4","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:01:46Z","timestamp":1764172906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Catastrophic antiphospholipid syndrome following surgery for Libman\u2013Sacks endocarditis: A case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Yinxia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"3692_CR1","unstructured":"Ibrahim AM, Siddique MS. Libman-Sacks Endocarditis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Sep 4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537191\/"},{"issue":"4","key":"3692_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jcu.22180","volume":"43","author":"Y Wang","year":"2015","unstructured":"Wang Y, Ma C, Yang J, Liu S, Zhang Y, Zhao L, Guan Z, Wei H, Gu T. Libman-sacks endocarditis exclusively involving the tricuspid valve in a patient with systemic lupus erythematosus. J Clin Ultrasound. 2015;43(4):265\u20137. https:\/\/doi.org\/10.1002\/jcu.22180. Epub 2014 Jun 13. PMID: 24925796.","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"3692_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jsha.2015.09.003","volume":"28","author":"A Akhlaq","year":"2016","unstructured":"Akhlaq A, Ali TA, Fatimi SH. Mitral valve replacement in systemic lupus erythematosus associated Libman-Sacks endocarditis. J Saudi Heart Assoc. 2016;28(2):124\u20136. https:\/\/doi.org\/10.1016\/j.jsha.2015.09.003.","journal-title":"J Saudi Heart Assoc"},{"issue":"1","key":"3692_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101463","volume":"34","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR. Antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2020;34(1):101463. https:\/\/doi.org\/10.1016\/j.berh.2019.101463.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"3692_CR5","first-page":"177","volume":"26","author":"X Yang","year":"2020","unstructured":"Yang X, Li DJ. Key points and progress of diagnosis and treatment of catastrophic antiphospholipid syndrome. Chin J Thromb Hemost. 2020;26(1):177\u201380.","journal-title":"Chin J Thromb Hemost"},{"issue":"19","key":"3692_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1056\/NEJM199611073351903","volume":"335","author":"CA Roldan","year":"1996","unstructured":"Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335(19):1424\u201330. https:\/\/doi.org\/10.1056\/NEJM199611073351903.","journal-title":"N Engl J Med"},{"issue":"8","key":"3692_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/01.cir.93.8.1579","volume":"93","author":"M Hojnik","year":"1996","unstructured":"Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93(8):1579\u201387. https:\/\/doi.org\/10.1161\/01.cir.93.8.1579.","journal-title":"Circulation"},{"issue":"3","key":"3692_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/s0735-1097(97)00211-8","volume":"30","author":"KW Klarich","year":"1997","unstructured":"Klarich KW, Enriquez-Sarano M, Gura GM, Edwards WD, Tajik AJ, Seward JB. Papillary fibroelastoma: echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol. 1997;30(3):784\u201390. https:\/\/doi.org\/10.1016\/s0735-1097(97)00211-8.","journal-title":"J Am Coll Cardiol"},{"issue":"2\u20133","key":"3692_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12016-008-8113-y","volume":"36","author":"JL Lee","year":"2009","unstructured":"Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol. 2009;36(2\u20133):126\u201330. https:\/\/doi.org\/10.1007\/s12016-008-8113-y.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3692_CR10","doi-asserted-by":"publisher","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633\u20138. https:\/\/doi.org\/10.1086\/313753.","DOI":"10.1086\/313753"},{"issue":"7","key":"3692_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","volume":"120","author":"I Moyssakis","year":"2007","unstructured":"Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120(7):636\u201342. https:\/\/doi.org\/10.1016\/j.amjmed.2007.01.024.","journal-title":"Am J Med"},{"issue":"2","key":"3692_CR12","first-page":"224","volume":"35","author":"CA Roldan","year":"2008","unstructured":"Roldan CA, Qualls CR, Sopko KS, Sibbitt WL Jr. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. J Rheumatol. 2008;35(2):224\u20139. Epub 2007 Dec 15. PMID: 18085739.","journal-title":"J Rheumatol"},{"issue":"4","key":"3692_CR13","first-page":"375","volume":"16","author":"L Gross","year":"1940","unstructured":"Gross L. The cardiac lesions in Libman-Sacks disease: with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol. 1940;16(4):375\u2013408. PMID: 19970511; PMCID: PMC1965099.","journal-title":"Am J Pathol"},{"issue":"2","key":"3692_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejcts.2007.11.004","volume":"33","author":"H Gorki","year":"2008","unstructured":"Gorki H, Malinovski V, Stanbridge RD. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg. 2008;33(2):168\u201381. https:\/\/doi.org\/10.1016\/j.ejcts.2007.11.004.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"3692_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jtcvs.2003.07.016","volume":"127","author":"Y Berkun","year":"2004","unstructured":"Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2004;127(2):414\u201320. https:\/\/doi.org\/10.1016\/j.jtcvs.2003.07.016.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"3692_CR16","doi-asserted-by":"publisher","first-page":"e36275","DOI":"10.7759\/cureus.36275","volume":"15","author":"AK Mandal","year":"2023","unstructured":"Mandal AK, Heer RS, Petrou M, Missouris CG. Recurrent nonbacterial thrombotic endocarditis and primary antiphospholipid antibody syndrome. Cureus. 2023;15(3):e36275. https:\/\/doi.org\/10.7759\/cureus.36275. PMID: 37073185; PMCID: PMC10105903.","journal-title":"Cureus"},{"issue":"1","key":"3692_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11926-010-0149-3","volume":"13","author":"M Barbhaiya","year":"2011","unstructured":"Barbhaiya M, Erkan D. Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand? Curr Rheumatol Rep. 2011;13(1):59\u201369. https:\/\/doi.org\/10.1007\/s11926-010-0149-3.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"3692_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.autrev.2018.03.011","volume":"17","author":"R Paule","year":"2018","unstructured":"Paule R, Morel N, Le Guern V, Fredi M, Coutte L, Belhocine M, et al. Classification of primary antiphospholipid syndrome as systemic lupus erythematosus: analysis of a cohort of 214 patients. Autoimmun Rev. 2018;17(9):866\u201372. https:\/\/doi.org\/10.1016\/j.autrev.2018.03.011.","journal-title":"Autoimmun Rev"},{"key":"3692_CR19","doi-asserted-by":"publisher","unstructured":"Djokovi\u0107 A, Stojanovi\u0107 L. [Cardiac Manifestations in Antiphospholipid Syndrome\u2013A Brief Review of the Literature]. Srp Arh Celok Lek. 2015 May-Jun;143(5\u20136):346\u2009\u2013\u200953. Serbian. https:\/\/doi.org\/10.2298\/sarh1506346d. PMID: 26259412.","DOI":"10.2298\/sarh1506346d"},{"issue":"2","key":"3692_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2796.2011.02362.x","volume":"270","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, de Groot PG, Pengo V. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J Intern Med. 2011;270(2):110\u201322. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02362.x.","journal-title":"J Intern Med"},{"issue":"2","key":"3692_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3692_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","volume":"124","author":"S Zuily","year":"2011","unstructured":"Zuily S, Regnault V, Selton-Suty C, Eschw\u00e8ge V, Bruntz JF, Bode-Dotto E, et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation. 2011;124(2):215\u201324. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.028522.","journal-title":"Circulation"},{"issue":"2","key":"3692_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/0961203310395051","volume":"20","author":"R Cervera","year":"2011","unstructured":"Cervera R, Tektonidou MG, Espinosa G, Cabral AR, Gonz\u00e1lez EB, Erkan D, et al. Task force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011;20(2):165\u201373. https:\/\/doi.org\/10.1177\/0961203310395051.","journal-title":"Lupus"},{"issue":"5","key":"3692_CR24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.semarthrit.2015.09.005","volume":"45","author":"SI Mavrogeni","year":"2016","unstructured":"Mavrogeni SI, Sfikakis PP, Kitas GD, Kolovou G, Tektonidou MG. Cardiac involvement in antiphospholipid syndrome: the diagnostic role of noninvasive cardiac imaging. Semin Arthritis Rheum. 2016;45(5):611\u20136. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.09.005.","journal-title":"Semin Arthritis Rheum"},{"key":"3692_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00941","volume":"10","author":"T Kolitz","year":"2019","unstructured":"Kolitz T, Shiber S, Sharabi I, Winder A, Zandman-Goddard G. Cardiac manifestations of antiphospholipid syndrome with focus on its primary form. Front Immunol. 2019;10:941. https:\/\/doi.org\/10.3389\/fimmu.2019.00941.","journal-title":"Front Immunol"},{"key":"3692_CR26","unstructured":"Zavaleta NE, Montes RM, Soto ME, Vanzzini NA, Amigo MC. Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study. J Rheumatol. 2004;31(12):2402-7. PMID: 15570641."},{"issue":"7","key":"3692_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1191\/0961203303lu391oa","volume":"12","author":"M Lockshin","year":"2003","unstructured":"Lockshin M, Tenedios F, Petri M, McCarty G, Forastiero R, Krilis S, et al. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus. 2003;12(7):518\u201323. https:\/\/doi.org\/10.1191\/0961203303lu391oa.","journal-title":"Lupus"},{"issue":"2","key":"3692_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1034\/j.1399-3003.2000.15b28.x","volume":"15","author":"M Wolf","year":"2000","unstructured":"Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15(2):395\u20139. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.15b28.x.","journal-title":"Eur Respir J"},{"issue":"6","key":"3692_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.berh.2007.10.003","volume":"21","author":"G Ruiz-Irastorza","year":"2007","unstructured":"Ruiz-Irastorza G, Khamashta MA. The treatment of antiphospholipid syndrome: a harmonic contrast. Best Pract Res Clin Rheumatol. 2007;21(6):1079\u201392. https:\/\/doi.org\/10.1016\/j.berh.2007.10.003.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"3692_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytab445","volume":"5","author":"F Haertel","year":"2021","unstructured":"Haertel F, Kretzschmar D, Schulze PC, Neumann T. Immunomodulation in antiphospholipid-antibody-associated endocarditis: a case report and review of the literature. Eur Heart J. 2021;5(12):ytab445. https:\/\/doi.org\/10.1093\/ehjcr\/ytab445.","journal-title":"Eur Heart J"},{"issue":"7","key":"3692_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530\u20134. https:\/\/doi.org\/10.1191\/0961203303lu394oa.","journal-title":"Lupus"},{"issue":"12","key":"3692_CR32","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10067-007-0634-x","volume":"26","author":"W Miesbach","year":"2007","unstructured":"Miesbach W, Asherson RA, Cervera R, Shoenfeld Y, Puerta JG, Espinosa G, et al. The role of malignancies in patients with catastrophic anti-phospholipid (Asherson\u2019s) syndrome. Clin Rheumatol. 2007;26(12):2109\u201314. https:\/\/doi.org\/10.1007\/s10067-007-0634-x.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"3692_CR33","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","volume":"14","author":"M Garcia-Carrasco","year":"2015","unstructured":"Garcia-Carrasco M, Mendoza-Pinto C, Macias-Diaz S, Vazquez de Lara F, Etchegaray-Morales I, Galvez-Romero JL, Mendez-Martinez S, Cervera R. The role of infectious diseases in the catastrophic antiphospholipid syndrome. Autoimmun Rev. 2015;14(11):1066\u201371. Epub 2015 Jul 22. PMID: 26209907.","journal-title":"Autoimmun Rev"},{"key":"3692_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.09.2009.2243","volume":"2010","author":"AM Wani","year":"2010","unstructured":"Wani AM, Hussain WM, Mejally MA, Ali KS, Raja SH, Maimani WA, et al. Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome. BMJ Case Rep. 2010;2010:bcr09.2009.2243. https:\/\/doi.org\/10.1136\/bcr.09.2009.2243.","journal-title":"BMJ Case Rep"},{"key":"3692_CR35","unstructured":"Kupferminc MJ, Lee MJ, Green D, Peaceman AM. Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies. Obstet Gynecol. 1994;83(5 Pt 2):806-7. PMID: 8159356."},{"issue":"4","key":"3692_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0002-9343(98)00061-8","volume":"104","author":"CS Kitchens","year":"1998","unstructured":"Kitchens CS. Thrombotic storm: when thrombosis begets thrombosis. Am J Med. 1998;104(4):381\u20135. https:\/\/doi.org\/10.1016\/s0002-9343(98)00061-8.","journal-title":"Am J Med"},{"issue":"5","key":"3692_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1160\/TH12-03-0212","volume":"109","author":"A Bontadi","year":"2013","unstructured":"Bontadi A, Ruffatti A, Falcinelli E, Giannini S, Marturano A, Tonello M, et al. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. Thromb Haemost. 2013;109(5):901\u20138. https:\/\/doi.org\/10.1160\/TH12-03-0212.","journal-title":"Thromb Haemost"},{"issue":"6","key":"3692_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","volume":"7","author":"PL Meroni","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330\u20139. https:\/\/doi.org\/10.1038\/nrrheum.2011.52.","journal-title":"Nat Rev Rheumatol"},{"key":"3692_CR39","doi-asserted-by":"publisher","unstructured":"Triplett DA, Asherson RA. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol. 2000;65(2):154-9. https:\/\/doi.org\/10.1002\/1096-8652(200010)65:2%3C154::aid-ajh11%3E3.0.co;2-a. PMID: 10996834.","DOI":"10.1002\/1096-8652(200010)65:2%3C154::aid-ajh11%3E3.0.co;2-a"},{"issue":"1","key":"3692_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-0031-1300951","volume":"38","author":"K Chapman","year":"2012","unstructured":"Chapman K, Seldon M, Richards R. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13. Semin Thromb Hemost. 2012;38(1):47\u201354. https:\/\/doi.org\/10.1055\/s-0031-1300951.","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"3692_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","volume":"13","author":"R Cervera","year":"2014","unstructured":"Cervera R, Rodr\u00edguez-Pint\u00f3 I, Colafrancesco S, Conti F, Valesini G, Ros\u00e1rio C, et al. 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome. Autoimmun Rev. 2014;13(7):699\u2013707. https:\/\/doi.org\/10.1016\/j.autrev.2014.03.002.","journal-title":"Autoimmun Rev"},{"key":"3692_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/915309","volume":"2013","author":"GB Vieregge","year":"2013","unstructured":"Vieregge GB, Harrington TJ, Andrews DM, Carpintero MF, Green DF, Nayer A. Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications. Case Rep Med. 2013;2013:915309. https:\/\/doi.org\/10.1155\/2013\/915309.","journal-title":"Case Rep Med"},{"issue":"1","key":"3692_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-009-0073-6","volume":"12","author":"R Cervera","year":"2010","unstructured":"Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep. 2010;12(1):70\u20136. https:\/\/doi.org\/10.1007\/s11926-009-0073-6.","journal-title":"Curr Rheumatol Rep"},{"key":"3692_CR44","doi-asserted-by":"publisher","unstructured":"Asherson RA. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus. 1998;7 Suppl 2:S55-62. https:\/\/doi.org\/10.1177\/096120339800700214. PMID: 9814675.","DOI":"10.1177\/096120339800700214"},{"issue":"10","key":"3692_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/0961203309106833","volume":"18","author":"S Bucciarelli","year":"2009","unstructured":"Bucciarelli S, Espinosa G, Cervera R. The CAPS registry: morbidity and mortality of the catastrophic antiphospholipid syndrome. Lupus. 2009;18(10):905\u201312. https:\/\/doi.org\/10.1177\/0961203309106833.","journal-title":"Lupus"},{"issue":"4","key":"3692_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-0042-104121","volume":"228","author":"M Albinski","year":"2016","unstructured":"Albinski M, Hufnagel M, Schelling J, Fleck T, Siepe M, Zieger B, et al. Cardiac thrombus with risk of fulminant pulmonary embolism in paediatric antiphospholipid syndrome. Klin Padiatr. 2016;228(4):219\u201322. https:\/\/doi.org\/10.1055\/s-0042-104121.","journal-title":"Klin Padiatr"},{"issue":"2","key":"3692_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.autrev.2006.06.009","volume":"6","author":"R Cervera","year":"2006","unstructured":"Cervera R, Espinosa G, Bucciarelli S, G\u00f3mez-Puerta JA, Font J. Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev. 2006;6(2):81\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2006.06.009.","journal-title":"Autoimmun Rev"},{"key":"3692_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-224172","author":"LM Thomas","year":"2018","unstructured":"Thomas LM, Shaikh NA, Pradeep R. An extraordinary case of recurrent stroke, disseminated thrombosis and endocarditis. BMJ Case Rep. 2018;2018:bcr2018224172. https:\/\/doi.org\/10.1136\/bcr-2018-224172."},{"key":"3692_CR49","doi-asserted-by":"publisher","unstructured":"Yamamoto H, Iwade T, Nakano R, Mohri M, Amari Y, Noma M. Images in cardiovascular medicine. Numerous small vegetations revealing Libman-Sacks endocarditis in catastrophic antiphospholipid syndrome. Circulation. 2007;116(20):e531-5. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.726943. PMID: 17998465.","DOI":"10.1161\/CIRCULATIONAHA.107.726943"},{"issue":"1","key":"3692_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijcard.2007.05.043","volume":"128","author":"P Pugliatti","year":"2008","unstructured":"Pugliatti P, Di Bella G, Recupero A, Patan\u00e8 S, Coglitore S. Non compaction cardiomyopathy and antiphospholipid syndrome: a catastrophic thromboembolic association. Int J Cardiol. 2008;128(1):126\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2007.05.043.","journal-title":"Int J Cardiol"},{"issue":"5","key":"3692_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytac199","volume":"6","author":"N Mittal","year":"2022","unstructured":"Mittal N, Abohelwa M, Rahman MR, Shurmur S. Cardiovascular complications of catastrophic antiphospholipid syndrome: a case report and review of literature. Eur Heart J. 2022;6(5):ytac199. https:\/\/doi.org\/10.1093\/ehjcr\/ytac199.","journal-title":"Eur Heart J"},{"issue":"1","key":"3692_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-225495","volume":"12","author":"J Cranley","year":"2019","unstructured":"Cranley J, Krishnan U, Tweed K, Duehmke RM. Catastrophic antiphospholipid syndrome causing ST-segment elevation myocardial infarction with non-obstructive coronary arteries. BMJ Case Rep. 2019;12(1):bcr-2018-225495. https:\/\/doi.org\/10.1136\/bcr-2018-225495.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"3692_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.14503\/THIJ-17-6472","volume":"46","author":"IM Tulai","year":"2019","unstructured":"Tulai IM, Penciu OM, Raut R, Rudinskaya A. Catastrophic antiphospholipid syndrome presenting as congestive heart failure in a patient with thrombotic microangiopathy. Tex Heart Inst J. 2019;46(1):48\u201352. https:\/\/doi.org\/10.14503\/THIJ-17-6472.","journal-title":"Tex Heart Inst J"},{"issue":"7","key":"3692_CR54","first-page":"1313","volume":"25","author":"ME Martinuzzo","year":"1998","unstructured":"Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol. 1998;25(7):1313\u20139. PMID: 9676762.","journal-title":"J Rheumatol"},{"issue":"6","key":"3692_CR55","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/ard.62.6.530","volume":"62","author":"D Erkan","year":"2003","unstructured":"Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, Lockshin MD, Catastrophic Antiphospholipid Syndrome Registry Project Group. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003;62(6):530\u20133. https:\/\/doi.org\/10.1136\/ard.62.6.530. PMID: 12759289; PMCID: PMC1754574.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"3692_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17116\/terarkh201587917-25","volume":"87","author":"DS Tuter","year":"2015","unstructured":"Tuter DS, Tuter DS, Kopylov FY, Kozlovskaya NL, Demyanova KA, Shchekochikhin DY. Cardiac involvement in thrombotic microangiopathies. Ter Arkh. 2015;87(9):17\u201325. https:\/\/doi.org\/10.17116\/terarkh201587917-25.","journal-title":"Ter Arkh"},{"key":"3692_CR57","doi-asserted-by":"publisher","unstructured":"Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese guideline on the diagnosis and management of thrombotic thrombocytopenic purpura (2022)]. Zhonghua Xue Ye Xue Za Zhi. 2022;43(1):7\u201312. Chinese. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2022.01.002. PMID: 35231985; PMCID: PMC8980665.","DOI":"10.3760\/cma.j.issn.0253-2727.2022.01.002"},{"issue":"9","key":"3692_CR58","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jocs.12811","volume":"31","author":"KB Sukniam","year":"2016","unstructured":"Sukniam KB, Proia AD, Glower DD. Catastrophic antiphospholipid syndrome after cardiac surgery. J Card Surg. 2016;31(9):584\u20136. https:\/\/doi.org\/10.1111\/jocs.12811.","journal-title":"J Card Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03692-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03692-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:01:48Z","timestamp":1764172908000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03692-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3692"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03692-4","relation":{"references":[{"id-type":"doi","id":"10.1136\/bcr-2018-224172","asserted-by":"subject"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine. We obtained signed informed consent from the legal guardians in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}